XML 80 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2013
Segment Reporting [Abstract] |
Segment Information | Segment Information Effective January 1, 2013, to better indicate operating performance, the company eliminated the allocation of non-operating pension and other postretirement employee benefit costs from segment pre-tax operating income (loss) (PTOI). Segment PTOI is defined as income (loss) from continuing operations before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. Certain reclassifications of prior year data have been made to conform to current year classifications.
Three Months Ended September 30, | Agriculture 1 | Electronics & Communications | Industrial Biosciences | Nutrition & Health | Performance Chemicals | Performance Materials | Safety & Protection | Pharm-aceuticals | Other | Total
2013 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 1,633 |  |  | $ | 638 |  |  | $ | 305 |  |  | $ | 868 |  |  | $ | 1,720 |  |  | $ | 1,663 |  |  | $ | 985 |  |  | $ | — |  |  | $ | 1 |  |  | $ | 7,813 |
Less: Transfers | 3 |  |  | 3 |  |  | 3 |  |  | — |  |  | 46 |  |  | 22 |  |  | 1 |  |  | — |  |  | — |  |  | 78 |
Net sales | 1,630 |  |  | 635 |  |  | 302 |  |  | 868 |  |  | 1,674 |  |  | 1,641 |  |  | 984 |  |  | — |  |  | 1 |  |  | 7,735 |
PTOI | (102 | ) | 2 |  | 97 |  |  | 45 |  |  | 81 |  |  | 182 |  | 3 |  | 374 |  |  | 171 |  |  | 5 |  |  | (112 | ) |  | 741 |
2012 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 1,423 |  |  | $ | 607 |  |  | $ | 292 |  |  | $ | 876 |  |  | $ | 1,732 |  |  | $ | 1,614 |  |  | $ | 934 |  |  | $ | — |  |  | $ | 2 |  |  | $ | 7,480 |
Less: Transfers | — |  |  | 4 |  |  | 3 |  |  | — |  |  | 56 |  |  | 24 |  |  | 3 |  |  | — |  |  | — |  |  | 90 |
Net sales | 1,423 |  |  | 603 |  |  | 289 |  |  | 876 |  |  | 1,676 |  |  | 1,590 |  |  | 931 |  |  | — |  |  | 2 |  |  | 7,390 |
PTOI | (198 | ) | 2,6 |  | (99 | ) | 6,7 | 37 |  | 6 |  | 64 |  | 6 |  | 410 |  | 6 |  | 230 |  | 6,7 | 92 |  | 6 |  | 10 |  |  | (85 | ) |  | 461 |
Nine Months Ended September 30, | Agriculture 1 | Electronics & Communications | Industrial Biosciences | Nutrition & Health | Performance Chemicals | Performance Materials | Safety & Protection | Pharm-aceuticals | Other | Total
2013 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 9,933 |  |  | $ | 1,907 |  |  | $ | 898 |  |  | $ | 2,601 |  |  | $ | 5,087 |  |  | $ | 4,892 |  |  | $ | 2,909 |  |  | $ | — |  |  | $ | 5 |  |  | $ | 28,232 |
Less: Transfers | 10 |  |  | 12 |  |  | 10 |  |  | — |  |  | 153 |  |  | 57 |  |  | 3 |  |  | — |  |  | — |  |  | 245 |
Net sales | 9,923 |  |  | 1,895 |  |  | 888 |  |  | 2,601 |  |  | 4,934 |  |  | 4,835 |  |  | 2,906 |  |  | — |  |  | 5 |  |  | 27,987 |
PTOI | 2,240 |  | 2 |  | 241 |  |  | 129 |  |  | 218 |  |  | 697 |  | 3 |  | 1,002 |  |  | 481 |  |  | 27 |  |  | (276 | ) |  | 4,759 |
2012 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 8,891 |  |  | $ | 2,079 |  |  | $ | 880 |  |  | $ | 2,569 |  |  | $ | 5,600 |  |  | $ | 4,913 |  |  | $ | 2,861 |  |  | $ | — |  |  | $ | 4 |  |  | $ | 27,797 |
Less: Transfers | 4 |  |  | 13 |  |  | 8 |  |  | — |  |  | 202 |  |  | 74 |  |  | 9 |  |  | — |  |  | — |  |  | 310 |
Net sales | 8,887 |  |  | 2,066 |  |  | 872 |  |  | 2,569 |  |  | 5,398 |  |  | 4,839 |  |  | 2,852 |  |  | — |  |  | 4 |  |  | 27,487 |
PTOI | 1,772 |  | 2,6 |  | 181 |  | 4,6,7 | 118 |  | 6 |  | 248 |  | 6 |  | 1,575 |  | 6 |  | 851 |  | 6,7 | 432 |  | 6 |  | 53 |  |  | (385 | ) | 5 |  | 4,845 |
1 | As of September 30, 2013, Agriculture net assets were $9,692, an increase of $4,936 from $4,756 at December 31, 2012. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
2 | Included charges of $(65) and $(180), offset by $25 of insurance recoveries, during the three and nine months ended September 30, 2013, respectively, and charges of $(125) and $(440) during the three and nine months ended September 30, 2012, respectively, recorded in other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 9 for additional information.
3 | Included a $(72) charge related to the titanium dioxide antitrust litigation. See Note 9 for additional information.
4 | Included a $122 gain recorded in other income, net related to the sale of the company's interest in an equity method investment.
5 | Included a $(137) charge recorded in other operating charges related to the company's settlement of litigation with INVISTA.
6 | Included a $(93) restructuring charge impacting the following segments: Agriculture - $(3), Electronics & Communications - $(7), Industrial Biosciences - $(3), Nutrition & Health - $(13), Performance Chemicals - $(3), Performance Materials - $(9), and Safety & Protection - $(55).
7 | Included a $(242) impairment charge recorded in employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150) and Performance Materials - $(92). See Note 3 for additional information.
Reconciliation to Consolidated Income Statements
| Three Months Ended September 30, | Nine Months Ended September 30,
| 2013 | 2012 | 2013 | 2012
Total segment PTOI | $ | 741 |  | $ | 461 |  | $ | 4,759 |  | $ | 4,845 |
Non-operating pension and other postretirement employee benefit costs | (142 | ) | (157 | ) | (415 | ) | (507 | )
Net exchange losses, including affiliates | (101 | ) | (130 | ) | (55 | ) | (161 | )
Corporate expenses | (162 | ) | (233 | ) | (582 | ) | (708 | )
Interest expense | (108 | ) | (116 | ) | (340 | ) | (347 | )
Income (loss) from continuing operations before income taxes | $ | 228 |  | $ | (175 | ) | $ | 3,367 |  | $ | 3,122 |

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration